H Ruud Delwel (Ruud Delwel)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Dna Methylation

Top Venues

Science advances

Nature communications

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro, Duncan Brian, Willy Noort, Julius Grasel, Remco Hoogenboezem, Leonie Smeenk, Jeroen A A Demmers, Michael D Milsom, Tariq Enver, Richard W J Groen, Eric M J Bindels, H Ruud Delwel
Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2. Science advances 10 (20) (2024)
Roger Mulet-Lazaro, Stanley van Herk, Margit Nuetzel, Aniko Sijs-Szabo, Noelia Díaz, Katherine Kelly, Claudia A J Erpelinck-Verschueren, Lucia Schwarzfischer-Pfeilschifter, Hanna Stanewsky, Ute Ackermann, Dagmar Glatz, Johanna Raithel, Alexander Fischer, Sandra Pohl, Anita Rijneveld, Juan M Vaquerizas, Christian Thiede, Christoph Plass, Bas J Wouters, H Ruud Delwel, Michael Rehli, Claudia Gebhard
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia. Nature communications 15 (1) (2024)
Roger Mulet-Lazaro, Stanley van Herk, Margit Nuetzel, Aniko Sijs-Szabo, Noelia Díaz, Katherine Kelly, Claudia A J Erpelinck-Verschueren, Lucia Schwarzfischer-Pfeilschifter, Hanna Stanewsky, Ute Ackermann, Dagmar Glatz, Johanna Raithel, Alexander Fischer, Sandra Pohl, Anita Rijneveld, Juan M Vaquerizas, Christian Thiede, Christoph Plass, Bas J Wouters, H Ruud Delwel, Michael Rehli, Claudia Gebhard
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia. Nature communications 15 (1) (2024)
Roger Mulet-Lazaro, H Ruud Delwel
Oncogenic Enhancers in Leukemia. Blood cancer discovery (2024)
Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro, Duncan Brian, Willy Noort, Julius Grasel, Remco Hoogenboezem, Leonie Smeenk, Jeroen A A Demmers, Michael D Milsom, Tariq Enver, Richard W J Groen, Eric M J Bindels, H Ruud Delwel
Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2. Science advances 10 (20) (2024)
Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro, Duncan Brian, Willy Noort, Julius Grasel, Remco Hoogenboezem, Leonie Smeenk, Jeroen A A Demmers, Michael D Milsom, Tariq Enver, Richard W J Groen, Eric M J Bindels, H Ruud Delwel
Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2. Science advances 10 (20) (2024)
Roger Mulet-Lazaro, H Ruud Delwel
Oncogenic Enhancers in Leukemia. Blood cancer discovery 5 (5) (2024)
Roger Mulet-Lazaro, Stanley van Herk, Margit Nuetzel, Aniko Sijs-Szabo, Noelia Díaz, Katherine Kelly, Claudia A J Erpelinck-Verschueren, Lucia Schwarzfischer-Pfeilschifter, Hanna Stanewsky, Ute Ackermann, Dagmar Glatz, Johanna Raithel, Alexander Fischer, Sandra Pohl, Anita Rijneveld, Juan M Vaquerizas, Christian Thiede, Christoph Plass, Bas J Wouters, H Ruud Delwel, Michael Rehli, Claudia Gebhard
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia. Nature communications 15 (1) (2024)
Assunta Adamo, Paulynn Suyin Chin, Peter Keane, Salam A Assi, Sandeep Potluri, Sophie G Kellaway, Daniel Coleman, Luke Ames, Anetta Ptasinska, H Ruud Delwel, Peter N Cockerill, Constanze Bonifer
Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia. Leukemia (2022)